Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03516214
Title EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations (EATON)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Cologne
Indications

lung non-small cell carcinoma

Therapies

Nazartinib + Trametinib

Age Groups: senior | adult
Covered Countries ESP | DEU


No variant requirements are available.